4
Changes in Ownership
Mereo BioPharma Group plc Filed Acc 0001193125-26-033751
Options or other derivatives
- Chief Executive Officer acquired 1,860,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Scots-Knight Denise Chief Executive Officer | 2026-02-01 | Grant or award · Share Options (Right to buy) | +1,035,000 | 1,035,000 | D: show line 1 in the form | |||||
| Scots-Knight Denise Chief Executive Officer | 2026-02-01 | Grant or award · Share Options (Right to buy) | +345,000 | 345,000 | D: show line 2 in the form | |||||
| Scots-Knight Denise Chief Executive Officer | 2026-02-01 | Grant or award · Share Options (Right to buy) | +480,000 | 480,000 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…